MARKHAM, ON, Oct. 15 /PRNewswire/ - Cytochroma today announced that it has appointed John Cunningham, CVO, BM BCh, DM, FRCP, to the Company's Scientific Advisory Board.
Dr. Cunningham is Professor of Nephrology at the UCL Medical School, London and Consultant Nephrologist at the Royal Free Hospital, London. His early training was at Cambridge and Oxford Universities, with postgraduate training in The University of London and
"We are delighted and honored that Dr. Cunningham has agreed to advise Cytochroma on its efforts to develop new drugs for secondary hyperparathyroidism in chronic kidney disease patients," said Charles W. Bishop, Ph.D., President and Chief Executive Officer of Cytochroma. "Dr. Cunningham's wealth of knowledge and clinical experience will be invaluable as we move our products through mid- and late-stage clinical trials."
Other members of Cytochroma's Scientific Advisory Board include: - Geoff Block, MD - Director of Clinical Research, Denver Nephrology - David Allen Bushinsky, MD - Professor of Medicine and of Pharmacology and Physiology, University of Rochester School of Medicine, and Chief, Nephrology Division, University of Rochester Medical Center - Russell Chesney, MD - Le Bonheur Professor and Chair, Department of Pediatrics, University of Tennessee Health S
Copyright©2009 PR Newswire.
All rights reserved